HLA-DQB2 and acute lymphoblastic leukemia: Among these genes, the partial control of human leucocyte antigen (HLA) genes like HLA-DQB2 on immune response to infection (45, 46) could be used as a reasonable therapeutic target, which will be further explored to revive the antitumor immunity in ALL.